Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma volume expansion with HES 130/0.4 vs crystalloids in hypotensive newborns
2004-002096-16Phase 4Terminated
- Sponsor
- Innsbruck University Children's Hospital
- Start
- Apr 2005
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Volulyte in hypotension (2 arms), sponsored by Innsbruck University Children's Hospital. Primary endpoint: Success rate of blood pressure correction. Started Apr 2005; status: terminated.
02
Drugs
Volulyte
03
Conditions
hypotension
Beyond the preview
Go deeper on 2004-002096-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002096-16.